Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Other Manufacturing
(316/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Indication
May 15, 2020
Blueprint Medicines Receives Complete Response Letter from FDA for Avapritinib New Drug Application for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Apr 16, 2020
Science and Technology Daily: Chinese Approach on Medical Treatment against COVID-19
Jan 08, 2020
AMCP Format for Formulary Submissions, Version 4.1, Includes New Dossiers for Submitting Evidence on Unapproved Medicines and Unapproved Indications Submitted for FDA Approval
Jan 07, 2020
IceCure Receives FDA Clearance for Expanded Indications of Cryoablation Technology and Regulatory Approval of New MultiSense System; Plans to Increase U.S. Presence and Operations
Nov 05, 2019
Blueprint Medicines Outlines Precision Therapy Research Vision, Provides Update on Discovery and Clinical-Stage Portfolio at R&D Day and Reports Third Quarter 2019 Financial Results
Oct 02, 2019
DURECT Announces FDA Advisory Committee Meeting to Review POSIMIR® for the Treatment of Post-Surgical Pain
Sep 24, 2019
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity
Sep 13, 2019
Statement from FDA's Center for Drug Evaluation and Research Director Janet Woodcock, M.D., alerting patients and health care professionals of NDMA found in samples of ranitidine
Aug 28, 2019
Veterinary Drug Approval Process and FDA Regulatory Course: Chicago, IL, United States - December 5-6, 2019
Aug 28, 2019
Two Day Veterinary Drug Approval Process and FDA Regulatory Oversight Seminar: Kansas City, United States - September 26-27, 2019
Aug 20, 2019
Global Syndromic Testing Markets, 2018-2023 - Continued Unnecessary Antibiotic Prescription Use
Aug 19, 2019
Sheba Researchers Find Significant Improvements in Patient Safety Standard Following Deployment of MedAware's Machine Learning-based Platform
Jul 17, 2019
DURECT Announces that the FDA Agreed to File the Full Response to the POSIMIR® Complete Response Letter as a Complete Class 2 Resubmission
Jun 27, 2019
DURECT Announces Submission to FDA of a Full Response to the POSIMIR® Complete Response Letter
Apr 11, 2019
FDA orders important safety labeling changes for Addyi
Apr 11, 2019
FDAnews Announces -- The Accelerated Approval Pathway for Drugs and Biologics: Final Labeling Guidance Webinar, April 25, 2019
Jan 17, 2019
Focus on Personalized Cancer Treatment Drives the Pharmacogenomics (PGx) Labelling of Oncology Drugs
Dec 06, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA's new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products
Latest News
Apr 26, 2024
OpenGate Capital Completes Sale of SMAC
Apr 26, 2024
Masonite Shareholders Approve Transaction with Owens Corning
Apr 26, 2024
Avery Dennison Increases Quarterly Dividend
Apr 26, 2024
ComEd Joins Bronzeville Community to Unveil New Public EV Chargers
Apr 26, 2024
OCOchem Advances Hydrogen Formate Electrolyzer Process By 10x To Create World’s Largest Industrial Scale CO2...
Apr 26, 2024
Canada Tractors Industry Analysis & Forecasts 2023-2024 and 2029: Technological Advancements and Shift...
Apr 26, 2024
Global and Regional Aircraft Fuel Cells Industry Research 2023-2033: Integration into Aircraft Systems Drives...
Apr 26, 2024
Leeward Renewable Energy Releases Inaugural Sustainability Highlights Report
View all News
Agenda
24
September
Hilton London Syon Park, London, UK
Defence Transformation Conference
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
View All Events